FENOFIBRATE RAN fenofibrate 145mg film coated tablets blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

fenofibrate, Quantity: 145 mg

Commercializzato da:

Sun Pharma ANZ Pty Ltd

INN (Nome Internazionale):

Fenofibrate

Forma farmaceutica:

Tablet

Composizione:

Excipient Ingredients: pregelatinised maize starch; silicon dioxide; sodium lauryl sulfate; microcrystalline cellulose; crospovidone; hypromellose; sucrose; sodium stearylfumarate; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin

Via di somministrazione:

Oral

Confezione:

30

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Fenofibrate is indicated as an adjunct to diet in the treatment of: - hypercholesterolaemia; - types II, III, IV and V dyslipidaemia; - dyslipidaemia associated with type 2 diabetes.

Dettagli prodotto:

Visual Identification: White to off-white, oval shaped, biconvex film coated tablets debossed with 'RH 38' on one side and other side plain; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2016-02-29